Aptevo Therapeutics Inc. (APVO) vs Mustang Bio, Inc. (MBIO)
A side-by-side comparison of Aptevo Therapeutics Inc. and Mustang Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APVO
Aptevo Therapeutics Inc.
$1.83HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
MBIO
Mustang Bio, Inc.
$0.46HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — APVO vs MBIO
growth of $100 · dividends reinvested · last 9yAPVO -100.0% (-82.6%/yr)MBIO -100.0% (-65.9%/yr)MBIO compounded faster over this window
Log scale — wide-divergence pair
APVO MBIO
APVO vs MBIO: by the numbers
- •APVO is the larger company ($4M vs $3M market cap).
Metrics side by side
Valuation
| Metric | APVO | MBIO |
|---|---|---|
| P/B ratio | 0.66 | 0.46 |
Profitability
| Metric | APVO | MBIO |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -437.15% | -40.20% |
| ROIC | -288.14% | -45.77% |
Growth (annualized)
| Metric | APVO | MBIO |
|---|---|---|
| Total return CAGR (5Y) | -95.30% | -80.80% |
Frequently asked
- How have APVO and MBIO total returns compared?
- Over the past 5 years, APVO delivered -95.30% and MBIO delivered -80.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.